Correlation Between Structure Therapeutics and Zura Bio
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Zura Bio Limited, you can compare the effects of market volatilities on Structure Therapeutics and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Zura Bio.
Diversification Opportunities for Structure Therapeutics and Zura Bio
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Structure and Zura is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Zura Bio go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Zura Bio
Given the investment horizon of 90 days Structure Therapeutics American is expected to under-perform the Zura Bio. But the stock apears to be less risky and, when comparing its historical volatility, Structure Therapeutics American is 1.06 times less risky than Zura Bio. The stock trades about -0.02 of its potential returns per unit of risk. The Zura Bio Limited is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 166.00 in Zura Bio Limited on January 27, 2025 and sell it today you would lose (29.00) from holding Zura Bio Limited or give up 17.47% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Structure Therapeutics America vs. Zura Bio Limited
Performance |
Timeline |
Structure Therapeutics |
Zura Bio Limited |
Structure Therapeutics and Zura Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Structure Therapeutics and Zura Bio
The main advantage of trading using opposite Structure Therapeutics and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Zura Bio vs. Ralph Lauren Corp | Zura Bio vs. Canada Goose Holdings | Zura Bio vs. Kontoor Brands | Zura Bio vs. Skechers USA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Transaction History View history of all your transactions and understand their impact on performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |